A Phase II, Open-label, Multicentre Study to Evaluate the Long-term Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease Who Have Completed the MT 1303-E13 Study
A Phase II, Open-label, Multicentre Study to Evaluate the Long-term Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease Who Have Completed the MT 1303-E13 Study
The primary objectives of the study are:
-To evaluate the long-term safety and tolerability of MT-1303 in subjects with moderate to severe active Crohn's Disease（CD）
Inclusion Criteria:
Exclusion Criteria:
City Name, Czechia
City Name, France
City Nmae, Germany
City Nmae, Hungary
City Name, Israel
City Name, Italy
City Nmae, Japan
City Name, Netherlands
City Name, Poland
City Name, Slovakia
City Name, Ukraine